The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Much Growth In Market Value Is Expected For The Glaucoma Drainage Devices Market Between 2026 And 2030?
The glaucoma drainage devices market size has experienced significant expansion in recent years. It is projected to advance from $0.89 billion in 2025 to $0.98 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 10.0%. The growth observed in the historic period can be attributed to the increasing prevalence of glaucoma, the expansion of ophthalmic surgical centers, the growing adoption of surgical glaucoma treatments, a rising aging population, and the availability of specialized eye care facilities.
The glaucoma drainage devices market size is projected to experience robust expansion over the next few years. It is expected to grow to $1.42 billion by 2030, achieving a compound annual growth rate (CAGR) of 9.7%. This expansion during the forecast period can be attributed to an increased need for minimally invasive eye operations, rising investments in ophthalmic device innovation, the broadening of advanced glaucoma care programs, a growing emphasis on early intervention, and technological advancements in implant materials and their design. Significant trends for the forecast period include the increasing adoption of minimally invasive glaucoma implants, a rising demand for valved drainage devices, a greater focus on sustained intraocular pressure control, the expansion of advanced biocompatible materials, and enhanced precision in surgical implant design.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20821&type=smp
Which Strong Drivers Are Impacting The Glaucoma Drainage Devices Market Growth?
The increasing prevalence of glaucoma conditions is expected to propel the growth of the Glaucoma Drainage Devices Market going forward. Glaucoma encompasses a group of eye disorders that damage the optic nerve, typically due to increased intraocular pressure, potentially resulting in vision loss if not addressed. The rising cases of glaucoma can be attributed to several factors, such as an aging population, urbanization, and lifestyle changes. Glaucoma drainage devices help manage intraocular pressure in refractory glaucoma by facilitating aqueous humor outflow when conventional treatments fail. For instance, in October 2025, according to The NHS Confederation, a UK-based membership organization, reported that glaucoma, the main cause of irreversible sight loss in the UK, affects over 700,000 people, nearly half of whom remain undiagnosed due to its symptomless nature and long hospital waits. NHS waiting times can reach 72 weeks, and major eye conditions are projected to rise 25% from 2022–2032, outpacing population growth sevenfold. Therefore, the increasing prevalence of glaucoma conditions is driving the growth of the Glaucoma Drainage Devices Market. The expansion in healthcare infrastructure is expected to propel the growth of the Glaucoma Drainage Devices Market going forward. Healthcare infrastructure refers to the network of hospitals, clinics, diagnostic centers, and supporting medical facilities that provide access to quality healthcare services for the population. The expansion of healthcare infrastructure is driven by increasing government and private sector investments, rising population, and growing demand for advanced medical care. Improved infrastructure supports the adoption of new medical technologies, increases patient access to care, and enhances the efficiency of healthcare delivery. For instance, in May 2023, according to a report published by the Office for National Statistics, a UK-based government department, between 2022 and 2023, healthcare spending in the UK increased by 5.6% compared with growth of 0.9% in 2022. The UK healthcare expenditure was around $317.63 billion (£292 billion) in 2023. Therefore, the expansion in healthcare infrastructure is driving growth in the Glaucoma Drainage Devices Market.
Which Segments Define The Glaucoma Drainage Devices Market Segment Structure?
The glaucoma drainage devices market covered in this report is segmented –
1) By Product Type: Valved Glaucoma Drainage Devices, Non-Valved Glaucoma Drainage Devices
2) By Surgery Type: Conventional Glaucoma Surgery, Minimally Invasive Glaucoma Surgery
3) By End-User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Other End-Users
Subsegments:
1) By Valved Glaucoma Drainage Devices: Ahmed Glaucoma Valve, Baerveldt Glaucoma Implant, Krupin Implant, Others
2) By Non-Valved Glaucoma Drainage Devices: Molteno Implant, Schocket Implant, Foster Implant, Others
Which Trends Are Contributing To Changes In The Glaucoma Drainage Devices Market?
Leading companies in the glaucoma drainage devices market are prioritizing the development of next-generation canal-based glaucoma surgery devices. This focus aims to deliver minimally invasive solutions and meet the rising demand for safer, more effective treatments. Canal-based glaucoma surgery devices are implants engineered to target Schlemm’s canal, thereby improving aqueous humor drainage and reducing intraocular pressure (IOP). This approach aids in glaucoma management by addressing the primary cause of the condition’s progression. For instance, in March 2023, Nova Eye Medical Limited, an Australia-based glaucoma devices manufacturer, obtained clearance for its iTrack Advance canaloplasty device. This innovative device is designed for microcatheterization and viscodilation to lower intraocular pressure (IOP) in adult patients diagnosed with primary open-angle glaucoma. The iTrack Advance incorporates an ergonomic handpiece and enhanced technology to boost surgical efficiency. It is intended for both standalone procedures and those performed in conjunction with cataract surgery.
Who Are The Established Players Within The Glaucoma Drainage Devices Market?
Major companies operating in the glaucoma drainage devices market are AbbVie Inc., Alcon Inc., Johnson And Johnson Vision Care Inc., Santen Pharmaceutical Co. Ltd., Glaukos Corporation, Ocular Therapeutix Inc., IRIDEX Corporation, New World Medical Inc., Ivantis Inc., iSTAR Medical, Nova Eye Medical Limited, Altomed, Aurolab, G.surgiwear Limited, Eagle Vision Inc., Advanced Ophthalmic Innovations Pte Ltd., Avisi Technologies Inc., iVeena Delivery Systems, Optonol Ltd., Rheon-medical
Get The Full Glaucoma Drainage Devices Market Report:
https://www.thebusinessresearchcompany.com/report/glaucoma-drainage-devices-global-market-report
Which Region Represents The Largest Share Of The Glaucoma Drainage Devices Market?
North America was the largest region in the glaucoma drainage devices market in 2025. The regions covered in the glaucoma drainage devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Glaucoma Drainage Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=20821&type=smp
Browse Through More Reports Similar to the Global Glaucoma Drainage Devices Market 2026, By The Business Research Company
Minimally Invasive Glaucoma Surgery Migs Devices Market Report 2026
Medical And Surgical Drainage System Market Report 2026
Cataract Surgery Devices And Equipment Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model